AI and Autonomy NetraMark demonstrates efficacy of AI to help with clinical trials AI analyzes huge amounts of data, finds patterns, and makes decisions on its own Joseph Morton4 days ago
Medical and Pharmaceutical Investors flock to psychedelic start-ups Sovereign wealth funds Temasek and Mubadala engage in discussions to finance biotech ventures Zartasha MushtaqFebruary 12, 2024
Health & Wellness AstraZeneca to expand US manufacturing for cell therapy Investment in AstraZeneca's new Rockville Facility to propel cancer treatment research and development Zartasha MushtaqFebruary 12, 2024
Medical and Pharmaceutical Expanding access: LillyDirect offers Zepbound directly to patients Eli Lilly introduces direct-to-patient portal for obesity drug access Zartasha MushtaqFebruary 9, 2024
Medical and Pharmaceutical Biogen ends 17-Year Aduhelm alzheimer’s drug study Aduhelm's troubled journey and the pursuit of new horizons Zartasha MushtaqFebruary 5, 2024
Cyber Security HEAL Security secures $4.6 million in funding for healthcare cybersecurity Enhancing healthcare data protection through pre-seed cybersecurity investment Zartasha MushtaqJanuary 26, 2024
Health & Wellness Microdosing LSD shows potential antidepressant effects in landmark study Results of the study were published in the journal Neuropsychopharmacology Zartasha MushtaqJanuary 20, 2024
Health & Wellness Compass Pathways, Hackensack Meridian Health collaborate on psilocybin treatment research Partnership signals a milestone agreement for innovative treatment solutions Zartasha MushtaqJanuary 19, 2024
AI and Autonomy WELL Health and HEALWELL AI bring artificial intelligence platform to healthcare providers The system accurately identifies more than 110 complex or rare diseases often missed by conventional methods Joseph MortonOctober 18, 2023
Cannabis Israel to loosen restrictions on medical cannabis, revoke license requirements for patients Pending approval from the country's Ministry of Health, exporting Israeli cannabis to Europe will become a less difficult process too Rowan DunneAugust 11, 2023